Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-002518

Options or other derivatives

  • Chief Executive Officer acquired 390,851 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Robinson Chandler · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-02-01 Grant or award : show line 1 in the form Stock Options +221,839 221,839 D
2023-02-01 Grant or award : show line 2 in the form Restricted Stock Units +169,012 326,907 D
Loading xslF345X03/rdgdoc.xml…